Your browser doesn't support javascript.
loading
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity.
Dressler, Dirk; Altavista, Maria Concetta; Altenmueller, Eckart; Bhidayasiri, Roongroj; Bohlega, Saeed; Chana, Pedro; Chung, Tae Mo; Colosimo, Carlo; Fheodoroff, Klemens; Garcia-Ruiz, Pedro J; Jeon, Beomseok; Jin, Lingjing; Kanovsky, Petr; Milanov, Ivan; Micheli, Federico; Orlova, Olga; Pandey, Sanjay; Pirtosek, Zvezdan; Relja, Maja; Rosales, Raymond; Sagástegui-Rodríguez, José Alberto; Shahidi, Gholam Ali; Timerbaeva, Sofia; Wan, Xinhua; Walter, Uwe; Saberi, Fereshte Adib.
Afiliação
  • Dressler D; Movement Disorders Section, Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. dressler.dirk@mh-hannover.de.
  • Altavista MC; Department of Neurology, A.C.O. San Filippo Neri, Rome, Italy.
  • Altenmueller E; Institute of Music Physiology and Musicians' Medicine, Hanover University of Music, Drama and Media, Hannover, Germany.
  • Bhidayasiri R; Chulalongkorn Centre for Excellence on Parkinson's Disease and Related Disorders, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Bohlega S; Department of Neurology, King Faisal Specialist Hospital, Riyyad, Kingdom of Saudi Arabia.
  • Chana P; Department of Neurology, University de Santiago de Chile, Santiago de Chile, Chile.
  • Chung TM; University of Sao Paulo, Sao Paulo, Brazil.
  • Colosimo C; Department of Neurology, Santa Maria University Hospital, Terni, Italy.
  • Fheodoroff K; Gailtal-Klinik, Hermagor, Austria.
  • Garcia-Ruiz PJ; Department of Neurology, Fundacion Jimenez Diaz, Madrid, Spain.
  • Jeon B; Department of Neurology, Seoul National University, Seoul, Republic of Korea.
  • Jin L; Department of Neurology, Tongji University School of Medicine, Shanghai, China.
  • Kanovsky P; Department of Neurology, Palacky University, Olomouc, Czech Republic.
  • Milanov I; Department of Neurology, Medical University of Sofia, Sofia, Bulgaria.
  • Micheli F; Department of Neurology, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.
  • Orlova O; Clinic 'Cecil Plus', Moscow, Russia.
  • Pandey S; Department of Neurology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi, India.
  • Pirtosek Z; Department of Neurology, Ljubljana University, Ljubljana, Slovenia.
  • Relja M; Department of Neurology, University of Zagreb, Zagreb, Croatia.
  • Rosales R; Department of Neurology, University of Santo Tomas, Manila, Philippines.
  • Sagástegui-Rodríguez JA; Department of Neurology, University of Monterrey, Monterrey, Nueva Leon, Mexico.
  • Shahidi GA; Department of Neurology, Iran University of Medical Sciences, Tehran, Iran.
  • Timerbaeva S; Scientific Research Institute of Neurology, Moscow, Russia.
  • Wan X; Department of Neurology, Peking Union Medical College, Beijing, China.
  • Walter U; Department of Neurology, Rostock University, Rostock, Germany.
  • Saberi FA; IAB-Interdisciplinary Working Group for Movement Disorders, Hamburg, Germany.
J Neural Transm (Vienna) ; 128(3): 321-335, 2021 03.
Article em En | MEDLINE | ID: mdl-33635442
ABSTRACT
Botulinum toxin (BT) therapy is a complex and highly individualised therapy defined by treatment algorithms and injection schemes describing its target muscles and their dosing. Various consensus guidelines have tried to standardise and to improve BT therapy. We wanted to update and improve consensus guidelines by (1) Acknowledging recent advances of treatment algorithms. (2) Basing dosing tables on statistical analyses of real-life treatment data of 1831 BT injections in 36 different target muscles in 420 dystonia patients and 1593 BT injections in 31 different target muscles in 240 spasticity patients. (3) Providing more detailed dosing data including typical doses, dose variabilities, and dosing limits. (4) Including total doses and target muscle selections for typical clinical entities thus adapting dosing to different aetiologies and pathophysiologies. (5) In addition, providing a brief and concise review of the clinical entity treated together with general principles of its BT therapy. For this, we collaborated with IAB-Interdisciplinary Working Group for Movement Disorders which invited an international panel of experts for the support.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Toxinas Botulínicas / Toxinas Botulínicas Tipo A / Distúrbios Distônicos / Distonia Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Neural Transm (Vienna) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Toxinas Botulínicas / Toxinas Botulínicas Tipo A / Distúrbios Distônicos / Distonia Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Neural Transm (Vienna) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha